CARPEM is an Integrated Cancer Research Site (SIRIC) that focuses on the development of new personalized cancer treatments while working on prevention.
SIRICs were set up by the French National Cancer Institute (INCa). The SIRIC label for our CARPEM programme is a recognition of the excellence of our research and clinical teams in cancer research, who have real know-how in translational research. Translational research is essential to bridge the gap between fundamental research (basic mechanisms) and clinical research (medical application).
To achieve our objectives, we have brought together the cancer research strengths of three major hospitals of the Assistance Publique des Hôpitaux de Paris, AP-HP (Georges Pompidou, Cochin and Necker).
CARPEM brings together 350 doctors and researchers dedicated to care and research.